West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 101,700 | 96,000 | 96,500 | 100,500 | 99,300 |
| Cost of Goods | 70,900 | 66,900 | 69,900 | 70,900 | 69,800 |
| Gross Profit | 30,800 | 29,100 | 26,600 | 29,600 | 29,500 |
| Operating Expenses | 19,400 | 18,200 | 17,300 | 23,800 | 19,100 |
| Operating Income | 12,300 | 11,800 | 10,200 | 6,700 | 11,200 |
| Interest Expense | 2,400 | 4,200 | 3,000 | 3,000 | 3,300 |
| Other Income | 200 | 1,500 | 0 | 200 | 300 |
| Pre-tax Income | 10,100 | 9,100 | 7,200 | 3,900 | 8,200 |
| Income Tax | 3,800 | 3,200 | 1,500 | 1,100 | 2,800 |
| Net Income Continuous | 6,300 | 5,900 | 5,700 | 2,800 | 5,300 |
| Net Income Discontinuous | -200 | -25,500 | 200 | 300 | 100 |
| Net Income | $6,100 | $-19,600 | $5,900 | $3,100 | $5,400 |
| EPS Basic Total Ops | 0.11 | -0.34 | 0.10 | 0.06 | 0.10 |
| EPS Basic Continuous Ops | 0.11 | 0.10 | 0.10 | 0.05 | 0.09 |
| EPS Basic Discontinuous Ops | -0.01 | -0.45 | 0.00 | 0.01 | 0.00 |
| EPS Diluted Total Ops | 0.11 | -0.34 | 0.10 | 0.06 | 0.10 |
| EPS Diluted Continuous Ops | 0.11 | 0.10 | 0.10 | 0.05 | 0.09 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.44 | 0.00 | 0.01 | 0.00 |
| EBITDA(a) | $20,200 | $19,800 | $18,100 | $14,700 | $19,200 |